446 related articles for article (PubMed ID: 22294702)
1. Radiation damage and radioprotectants: new concepts in the era of molecular medicine.
Koukourakis MI
Br J Radiol; 2012 Apr; 85(1012):313-30. PubMed ID: 22294702
[TBL] [Abstract][Full Text] [Related]
2. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
3. Can radiation risks to patients be reduced without reducing radiation exposure? The status of chemical radioprotectants.
Mettler FA; Brenner D; Coleman CN; Kaminski JM; Kennedy AR; Wagner LK
AJR Am J Roentgenol; 2011 Mar; 196(3):616-8. PubMed ID: 21343505
[TBL] [Abstract][Full Text] [Related]
4. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.
Peters GJ; van der Vijgh WJ
Eur J Cancer; 1995; 31A Suppl 1():S1-7. PubMed ID: 7577093
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced toxicities: the role of radioprotectants.
Curran WJ
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.
Katsanos KH; Briasoulis E; Tsekeris P; Batistatou A; Bai M; Tolis C; Capizzello A; Panelos I; Karavasilis V; Christodoulou D; Tsianos EV
J Exp Clin Cancer Res; 2010 Jun; 29(1):68. PubMed ID: 20537164
[TBL] [Abstract][Full Text] [Related]
7. Future development of amifostine as a radioprotectant.
Werner-Wasik M
Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
[TBL] [Abstract][Full Text] [Related]
8. Acute radiation effect in the brain in infant rats: Neurocognitive and histopathological examination.
Gorker I; Yurut-Caloglu V; Karadag H; Caloglu M; Altaner S; Cengiz H; Ozen A
J BUON; 2011; 16(2):297-303. PubMed ID: 21766501
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
Antonadou D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
[TBL] [Abstract][Full Text] [Related]
10. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Hensley ML; Schuchter LM; Lindley C; Meropol NJ; Cohen GI; Broder G; Gradishar WJ; Green DM; Langdon RJ; Mitchell RB; Negrin R; Szatrowski TP; Thigpen JT; Von Hoff D; Wasserman TH; Winer EP; Pfister DG
J Clin Oncol; 1999 Oct; 17(10):3333-55. PubMed ID: 10506637
[TBL] [Abstract][Full Text] [Related]
11. Sparing radiation-induced damage to the physis by radioprotectant drugs: laboratory analysis in a rat model.
Tamurian RM; Damron TA; Spadaro JA
J Orthop Res; 1999 Mar; 17(2):286-92. PubMed ID: 10221847
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
Mell LK; Movsas B
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1341-50. PubMed ID: 18798703
[TBL] [Abstract][Full Text] [Related]
13. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
Capizzi RL; Oster W
Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
[TBL] [Abstract][Full Text] [Related]
14. Protection of normal tissues from the cytotoxic effects of radiation therapy: focus on amifostine.
Mehta MP
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):14-6. PubMed ID: 9794996
[TBL] [Abstract][Full Text] [Related]
15. Amifostine and radiation therapy: past, present, and future.
Tannehill SP; Mehta MP
Semin Oncol; 1996 Aug; 23(4 Suppl 8):69-77. PubMed ID: 8783671
[TBL] [Abstract][Full Text] [Related]
16. Amifostine Treatment Mitigates the Damaging Effects of Radiation on Distraction Osteogenesis in the Murine Mandible.
Monson LA; Nelson NS; Donneys A; Farberg AS; Tchanque-Fossuo CN; Deshpande SS; Buchman SR
Ann Plast Surg; 2016 Aug; 77(2):164-8. PubMed ID: 27070667
[TBL] [Abstract][Full Text] [Related]
17. Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer.
Hu K; Ship JA; Harrison LB
Semin Oncol; 2003 Dec; 30(6 Suppl 18):40-8. PubMed ID: 14727239
[TBL] [Abstract][Full Text] [Related]
18. Radioprotective Effect of Flavonoids on Ionizing Radiation-Induced Brain Damage.
Wang Q; Xie C; Xi S; Qian F; Peng X; Huang J; Tang F
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287417
[TBL] [Abstract][Full Text] [Related]
19. Radioprotective effect of amifostine on parotid gland functioning is region dependent.
Konings AW; Faber H; Vissink A; Coppes RP
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1584-91. PubMed ID: 16297717
[TBL] [Abstract][Full Text] [Related]
20. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
Büntzel J; Glatzel M; Kuttner K; Weinaug R; Fröhlich D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):4-13. PubMed ID: 11917277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
